RGNX Regenxbio announces pricing of public offering of common stock and pre-funded warrants Regenxbio - expects gross proceeds of about $100
RGNX Regenxbio announces pricing of public offering of common stock and pre-funded warrants Regenxbio - expects gross proceeds of about $100M from offering - Prices public offering of 10M shares at $9 and 1.11M pre-funded warrants at $9 - Offering expected to close on July 20, 2026
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.